Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1510119
Name of medicinal product: Alvegesic vet. 10mg/ml
Active substances:
Butorphanol
Estonian, English, Latin
ATC code: QN02AF01
Dosage form: solution for injection
Route of administration: intravenous use; intramuscular use; subcutaneous use
Strengh: 10mg 1ml
Amount in package: 10ml 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance: Psychotropic
Additional information:  
Indication: HORSE As an analgesic: For relief of moderate to severe abdominal pain (alleviates abdominal pain associated with colic of gastrointestinal origin). As a sedative: For sedation after the administration of certain alpha2-adrenoceptor agonists (detomidine, romifidine). DOG As an analgesic: For relief of moderate visceral pain. As a sedative: For sedation in combination with certain alpha2-adrenoceptor agonists (medetomidine). As a pre-anaesthetic: For pre-anaesthesia as sole agent and in combination with acepromazine. As an anaesthetic: For anaesthesia in combination with medetomidine and ketamine. CAT As an analgesic for the relief of moderate pain: For pre-operative analgesia in combination with acepromazine/ketamine or xylazine/ketamine. For post- operative analgesia after small surgical procedures. As a sedative: For sedation in combination with certain alpha2-adrenoceptor agonists (medetomidine). As an anaesthetic: For anaesthesia in combination with medetomidine and ketamine.
Safety features: No
Summary of product characteristics (SPC):  (last updated July 3, 2020)
Package information leaflet (PIL): EST  (last updated October 27, 2020)
Labelling:  (last updated July 3, 2020)
Withdrawal time: Hobune: Lihale ja söödavatele kudedele: 0 päeva Piimale: 0 tundi
Species: kass, koer, hobune
Last imported to Estonia: May 14, 2021
Marketing authorization holder: V.M.D. 
Marketing authorization number: 1686 
Marketing authorization issued on: February 27, 2012 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Mutual recognition 
Entry/Changing date: January 22, 2024
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere